Abstract 4626: A TRIM24-like mutational signature predicts worse relapse-free survival (RFS) and overall survival (OS) in patients (pts) with metaplastic breast cancer (MpBC)
Clinton Yam(The University of Texas MD Anderson Cancer Center), Stacy L. Moulder(The University of Texas MD Anderson Cancer Center), Michelle Barton(Western University), Jeffrey T. Chang(Tufts University), Aundrietta D. Duncan(Io Therapeutics (United States)), Michael Z. Gilcrease(The University of Texas MD Anderson Cancer Center), Vrutant Shah(Houston Methodist)
Cited by 0
Related Papers
TRIM24 links a non-canonical histone signature to breast cancer
|Nature|2010|440
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316
p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
|PLoS Biology|2012|231
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
|Nature Communications|2018|149
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
|Neuro-Oncology|2011|145